Edarbi
utilized to manage hypertension to support optimal blood pressure levels.
Strengths: 40mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Angiotensin II Receptor Antagonist
- Pharmacological class
Sartan
- Contraindications
hypersensitivity to azilsartan; pregnancy; severe hepatic impairment
- Minor side effects
dizziness; fatigue
- Moderate side effects
diarrhoea; elevated blood creatinine
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
utilized to manage hypertension to support optimal blood pressure levels.
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store in the original packaging, below 25°C, away from moisture and light.
- Drug interactions
potassium-sparing diuretics; lithium; nsaids
- Pregnancy and breastfeeding
Pregnancy: must not be used. Breastfeeding: use is generally not recommended.
Precautions and warnings
monitor blood pressure regularly; use caution in patients with renal impairment; may cause hypotension
Serious side effects
angioedema — requires immediate medical attention; acute renal failure — requires immediate medical attention
Mechanism of action
Azilsartan blocks the action of angiotensin II, a chemical that narrows blood vessels. By inhibiting these receptors, it allows blood vessels to relax and widen, reducing blood pressure and improving overall cardiac efficiency.
Edarbi
utilized to manage hypertension to support optimal blood pressure levels.
Editorial Notes
- Active ingredient(s): Azilsartan
- Listed indication(s): Hypertension
Available option
- 90 tablets - 40 mg1490-40-mg-17832